# Enable Medicine Inc. — Form D

Enable Medicine Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-27. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-08-27
- Form: D
- Accession: 0001822661-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $3.6M
- Minimum investment: $1
- Investors: 15
- Date of first sale: 2020-08-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374213

## Issuer

- Name: Enable Medicine Inc.
- CIK: 0001822661
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1600 ADAMS DR. #221, MENLO PARK, CA, 94025
- Phone: (408) 585-9256

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Sunil Bodapati | Director | Menlo Park, CA |
| Aaron Mayer | Director | New York, NY |
| Sunil Bodapati | Executive Officer | Menlo Park, CA |

## More

- [CIK 1822661 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1822661&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001822661-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.